Sort
25,944 grants matching “neurodegeneration”
Longitudinal Relationships Among Sleep, Cognition and Alzheimer's Disease Biomarkers: Discerning Causal Associations, Mediators and Susceptibility
$3,217,148Susan S Redline · Brigham And Women'S Hospital · R01 · FY2021 · AG
Characterization of Antigen-Specific Immune Response in ALS
$3,213,011Wassim Elyaman · Columbia University Health Sciences · RF1 · FY2025 · NS
Genetic and clinical studies of Gaucher disease and other lysosomal disorders
$3,211,711Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2022 · HG
Mechanisms regulating neurodegeneration and repair
$3,207,428Claire Le Pichon · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
Dysfunctional lipid metabolism and peroxidation in chronic pain and neurodegeneration
$3,199,356Christopher Ramsden · National Institute On Aging · ZIA · FY2025 · AG
Achieving specificity in imaging neurodegeneration with visible light Optical Coherence Tomography
$3,198,179Vivek Jay Srinivasan · New York University School Of Medicine · OT2 · FY2025 · OD
Mapping amyloid, tau, and neurodegeneration markers with neuropsychiatric phenotypes and genotypes in Alzheimer's disease continuum using machine learning
$3,188,901Ganesh Chand · Washington University · RF1 · FY2025 · AG
Role of PS1 in neurodegeneration
$3,188,744Oksana Berezovska · Massachusetts General Hospital · RF1 · FY2019 · AG
A Systems Approach to Targeting Innate Immunity in AD
$3,188,314Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · U01 · FY2021 · AG
Escitalopram for Agitation in Alzheimer Disease
$3,183,018Constantine G Lyketsos · Johns Hopkins University · R01 · FY2016 · AG
Mitochondrial stress responses in neurodegeneration
$3,176,786Derek Narendra · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
AMP-Kinase as a target for neuroprotection in AD
$3,175,735Michael K Lee · University Of Minnesota · RF1 · FY2019 · AG
Brain - Plasma Proteomics Biomarker Discovery and Validation in the US and UK
$3,174,907Allan I Levey · Emory University · RF1 · FY2017 · AG
UCSD Alzheimer's Disease Research Center P50
$3,174,023Douglas R Galasko · University Of California, San Diego · P50 · FY2014 · AG
Circadian dysfunction and Epigenetic alterations in the pathogenesis of Alzheimer's Disease
$3,173,392Paula Alejandra Desplats · University Of California, San Diego · RF1 · FY2019 · AG
Diabetes and brain amyloid in middle aged Hispanics
$3,169,894Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2022 · AG
Dysfunction of the Autophagy-Lysosomal Pathway as a Common Mechanism of Neurodegeneration
$3,162,400Steven M Finkbeiner · J. David Gladstone Institutes · RF1 · FY2017 · AG
Genetics of Early Onset Parkinson's Disease: Mitochondrial Drivers of PD Pathogenesis
$3,154,937Derek Narendra · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Upstream pathogenesis in familial and sporadic frontotemporal dementia and motor neuron disease
$3,153,019William W Seeley · University Of California, San Francisco · RF1 · FY2025 · NS
Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease
$3,148,529John M. Sedivy · Brown University · P01 · FY2025 · AG
Vascular Contributions to Dementia and Genetic Risk Factors for Alzheimer's Disease
$3,135,849Arthur W Toga · University Of Southern California · P01 · FY2025 · AG
The regulation of synaptic transmission and neural circuit function
$3,133,617Wei Lu · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Diabetes and brain amyloid in middle aged Hispanics
$3,132,512Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2023 · AG
Prevention of Alzheimer Dementia and Cognitive Decline
$3,115,773John C S Breitner · Seattle Inst For Biomedical/Clinical Res · U01 · FY2009 · AG
Mechanisms, modeling and therapies of retinal and macular neurodegeneration
$3,114,999Anand Swaroop · National Eye Institute · ZIA · FY2020 · EY